To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 5 (PDF)

Found: Report Run Date: 23-Nov-2022, Page 1 Case Series Drug Analysis Print Name: MMRvaxPro Vaccine Analysis

Select Committee
Large Print - Statutory Sick Pay

Report Mar. 28 2024

Committee: Work and Pensions Committee (Department: Department for Work and Pensions)

Found: Large Print - Statutory Sick Pay Report

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 12 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: DTaP/IPV/Hib/HepB Vaccine

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 2 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: Hib/MenC Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 3 (PDF)

Found: Report Run Date: 19-Oct-2022, Page 1 Case Series Drug Analysis Print Name: FOI 22/996 DTaP/IPV/Hib/HepB

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022
Document: Freedom of Information request (FOI 22/1069) - attachment 2 (PDF)

Found: Report Run Date: 19-Oct-2022, Page 1 Case Series Drug Analysis Print Name: FOI 22/996 DTaP/IPV/Hib/HepB

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 3 (PDF)

Found: Report Run Date: 23-Nov-2022, Page 1 Case Series Drug Analysis Print Name: Infanrix Hexa Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 5 December 2022
Document: FOI 22/1102 - attachment 1 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: DTaP/IPV/Hib/HepB Vaccine

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/879 - attachment 1 (PDF)

Found: When using a Drug Analysis Print, you should remember that:  The likelihood of experiencing an adverse

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 1 (PDF)

Found: When using a Drug Analysis Print, you should remember that:  The likelihood of experiencing an adverse